TWELVE YEARS OF EXPERIENCE USING CHOLECYSTOJEJUNAL BY-PASS FOR PALLIATIVE TREATMENT OF ADVANCED PANCREATIC CANCER

BACKGROUND: The cholecistojejunal bypass is an important resource to treat obstructive jaundice due to advanced pancreatic cancer. AIM: To assess the early morbidity and mortality of patients with pancreatic cancer who underwent cholecystojejunal derivation, and to assess the success of this procedu...

Descripción completa

Detalles Bibliográficos
Autores principales: de OLIVEIRA, Marcos Belotto, SANTOS, Bruna do Nascimento, de MORICZ, André, PACHECO-JUNIOR, Adhemar Monteiro, SILVA, Rodrigo Altenfelder, PEIXOTO, Renata D’Alpino, CAMPOS, Tércio De
Formato: Online Artículo Texto
Lenguaje:English
Publicado: Colégio Brasileiro de Cirurgia Digestiva 2017
Materias:
Original Article
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC5630214/
https://www.ncbi.nlm.nih.gov/pubmed/29019562
http://dx.doi.org/10.1590/0102-6720201700030009

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC5630214/
https://www.ncbi.nlm.nih.gov/pubmed/29019562
http://dx.doi.org/10.1590/0102-6720201700030009

Ejemplares similares